2025-08-11 - Analysis Report
Okay, here's a report analyzing Procter & Gamble (PG) based on the provided data.

**Procter & Gamble (PG) Stock Analysis**

**0. Executive Summary**

This report provides an analysis of Procter & Gamble Co. (PG) stock, comparing its performance against the S&P 500 (VOO), examining recent stock movements, technical indicators, news events, and financial performance. PG is a multinational consumer goods corporation that specializes in a wide range of personal health/consumer health, and personal care and hygiene products. Overall, PG is underperforming the S&P 500, showing recent price weakness, but potentially strong long-term expected returns. However, it's crucial to consider recent news events and potential risks highlighted by analysts.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (PG):** 44.11%
*   **Cumulative Return (VOO):** 84.01%
*   **Deviation (PG - VOO):** -43.0%

*   **Deviation Range:**  Max: 36.1%, Min: -43.9%
*   **Relative Deviation:** 1.1 (Near the lower end of its historical deviation range compared to VOO)

**Analysis:** PG has significantly underperformed the S&P 500. The negative deviation of -43.0% indicates a substantial lag in returns. The relative deviation of 1.1 suggests that this underperformance is near the most negative end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year      | CAGR  | MDD   | Alpha | Beta | Cap(B) |
| :---------- | :---- | :---- | :---- | :--- | :----- |
| 2015-2017 | 21.0% | 7.9%  | 19.0% | 0.0  | 215.2  |
| 2016-2018 | 5.0%  | 56.7% | 10.0% | 0.1  | 215.3  |
| 2017-2019 | 30.0% | 56.7% | 7.0%  | 0.1  | 292.6  |
| 2018-2020 | 38.0% | 59.1% | 11.0% | 0.1  | 325.9  |
| 2019-2021 | 56.0% | 59.1% | 7.0%  | 0.1  | 383.2  |
| 2020-2022 | 24.0% | 74.7% | 18.0% | 0.1  | 355.0  |
| 2021-2023 | 30.0% | 74.7% | 10.0% | 0.3  | 343.2  |
| 2022-2024 | 8.0%  | 74.7% | -18.0% | 0.2  | 392.7  |
| 2023-2025 | -16.0% | 71.6% | -65.0% | 0.1  | 359.6  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  CAGR is recently negative.
*   **MDD (Maximum Drawdown):** High MDD values are recently recorded, suggesting significant potential losses.
*   **Alpha:** Alpha recently turned negative, indicating underperformance compared to the benchmark.
*   **Beta:** Consistently low Beta values suggest that PG's stock is less volatile than the market.
*   **Cap (B):** Market capitalization has fluctuated, indicating changes in investor sentiment.

**2. Recent Stock Price Movements**

*   **Current Price:** 153.51
*   **Previous Close:** 153.49
*   **Change:** 0.01
*   **5-day Moving Average:** 152.23
*   **20-day Moving Average:** 154.42
*   **60-day Moving Average:** 159.65

**Analysis:** The current price is slightly above the previous close. The 5-day moving average is below the 20-day and 60-day averages, suggesting a short-term downward trend. The price is below the 20-day and 60-day moving averages, suggesting recent price weakness.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 45.17 (Neutral)
*   **PPO:** -0.0065 (Slightly Oversold)
*   **Hybrid Signal:** cash_70%_Sell 0.5% of holdings (2 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Deviation Change:** 1.1 (+) Short-term increase
*   **Expected Return (%):** 1343.7

**Analysis:**

*   The MRI indicates a low level of market risk.
*   The RSI is in a neutral zone, neither overbought nor oversold.
*   The PPO is slightly negative, suggesting a minor oversold condition.
*   The Hybrid Signal suggests a cautious approach, recommending holding a high cash position and selling a small portion of holdings.
*   The recent positive change in relative deviation suggests a short-term increase.
*   The exceptionally high expected return should be viewed with caution and considered in the context of the stock's current underperformance and potential risks.

**4. Recent News & Significant Events**

*   **2025-08-09:** Major business developments, regulatory changes, or market events.
*   **2025-08-08:** Analyst discussions of recent performance and outlook.
*   **2025-08-11:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-08-07:** Market experts highlight risks and opportunities.

**Analysis:** Recent news indicates volatility and potential risks/opportunities. Investors should closely monitor news and company announcements.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
| :--------- | :--- | :----------- |
| 2025-04-24 | 1.58 | 19.78 B$     |
| 2025-01-22 | 1.94 | 21.88 B$     |
| 2024-10-18 | 1.65 | 21.74 B$     |
| 2024-04-19 | 1.56 | 20.20 B$     |
| 2025-04-24 | 1.56 | 20.20 B$     |

**Analysis:**

*   EPS (Earnings Per Share): EPS shows variability over the quarters.
*   Revenue: Revenue has also fluctuated but generally remains above $20 billion.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-06-30 | \$20.89B  | 49.11%        |
| 2025-03-31 | \$19.78B  | 50.98%        |
| 2024-12-31 | \$21.88B  | 52.39%        |
| 2024-09-30 | \$21.74B  | 52.06%        |
| 2024-06-30 | \$20.53B  | 49.60%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
| :----------- | :-------- | :---- |
| 2025-06-30 | \$52.01B  | 6.95% |
| 2025-03-31 | \$52.27B  | 7.21% |
| 2024-12-31 | \$51.17B  | 9.05% |
| 2024-09-30 | \$51.84B  | 7.64% |
| 2024-06-30 | \$50.29B  | 6.24% |

**Analysis:**

*   **Revenue:** Revenue shows some fluctuation but is generally consistent.
*   **Profit Margin:** Profit margins are consistently high, indicating good cost management and strong pricing power.
*   **Equity:** Equity has remained relatively stable.
*   **ROE (Return on Equity):** ROE has fluctuated, indicating variability in how effectively the company is using equity to generate profits.

**7. Overall Analysis and Recommendation**

PG is underperforming the S&P 500, and recent price action suggests continued weakness.  While the MRI indicates low market risk, the hybrid signal recommends a cautious approach. The extraordinarily high expected return should be interpreted with caution, considering the context of underperformance.  Recent news suggests monitoring for potential volatility. The company maintains strong profit margins, but recent trends in revenue, EPS, and ROE should be monitored.

**Recommendation:**  Given the underperformance, price weakness, and cautious signals, a neutral to slightly negative outlook is warranted.  Investors should closely monitor news, earnings, and analyst reports before making any investment decisions. The very high expected return should be viewed skeptically until supported by improved performance.
